 webmaster@psych.uic.edu
|
Clinical
Profile of an Atypical Antipsychotic: Risperidone
John
A. Davis and Nancy Chen
Table 3. Pearson
Correlation between EPS and numerous scales
at endpoint for haloperidol (N=83)
|
|
EPS
|
| PANSS
Total |
-0.05
|
| Negative
Symptoms Factor |
0.01
|
| Positive
Symptoms Factor |
-0.18
|
| Disorganized
Thoughts Factor |
-0.10
|
| Impulsivity/Hostility
Factor |
-0.01
|
| Anxiety/Depression
Factor |
0.15
|
| Haloperidol-responsive |
-0.13
|
| Haloperidol-nonresponsive |
0.02
|
| Dopamine-sensitive |
-0.20
|
| Serotonin-sensitive |
-0.01
|
Note: for the PANSS
total, five factors, haloperidol-responsive, haloperidol-nonresponsive,
serotonin-sensitive, and dopamine-sensitive scales, the more negative
the value, the more improvement. For EPS, the more positive the value,
the more EPS.
|
